Regular follow-up of BMI can be a guiding tool for mortality estimation among geriatric peritoneal dialysis patients suggests ...

We are pleased to expand commercial access to QUELIMMUNE and are extremely proud to be the only company to develop and commercialize a therapeutic device that has demonstrated clinical results to ...